Case Report

Incretin therapies have emerged as a promising treatment option with potential benefits for mitigating cardiometabolic side effects associated with antipsychotics; however, clinical trials have often excluded psychiatric populations.

Anxiety symptoms may be a factor correlated with depression treatment response, suggesting potential utility in screening for anxiety symptoms in assessing likelihood of success with ECT treatment.

A single dose of the LSD-derived drug MM120 dramatically reduced anxiety symptoms in adults with generalized anxiety disorder.

The authors comment on a recent study by Fava et al showing clinical evidence for a long-term antidepressant effect of esmethadone.